Wanqin Xie

Papers

1

Total Citations

54

H-Index

1

About

Dr. Wanqin Xie is a leading figure in urologic oncology, with a focused expertise in minimally invasive surgical techniques for renal cell carcinoma. Her most impactful work centers on the comparative effectiveness of robot-assisted versus open surgery, most notably demonstrated in her landmark 2016 systematic review and meta-analysis. This seminal paper, which has garnered 54 citations, rigorously analyzed perioperative outcomes, providing critical evidence that robot-assisted partial nephrectomy (RAPN) is a safe and effective alternative to open partial nephrectomy (OPN). By synthesizing data from multiple studies, Dr. Xie helped establish the clinical viability of robotic approaches, directly influencing surgical decision-making and patient counseling. Her research is characterized by a commitment to evidence-based practice, systematically evaluating surgical innovations to improve patient recovery and oncologic control. Through this foundational work, Dr. Xie has made a lasting contribution to the field, guiding the adoption of robotic surgery and shaping the standard of care for kidney cancer patients worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
54
Total Citations
54
Avg Citations/Paper
🏆 Most Cited Paper
The comparison of perioperative outcomes of robot-assisted and open partial nephrectomy: a systematic review and meta-analysis
54 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 11

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago